Mellitus, LLC
Biotechnology company · Boston, Massachusetts, United States
Mellitus, LLC is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2011. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $3.6 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $90,000 sold in a notice filed in 2023.
Mellitus at a glance
What does Mellitus do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $3.6 million in total (2019 to 2020). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
12 Form D notices; the most recent reported $90,000 sold (2023).
Frequently asked questions about Mellitus
Where is Mellitus headquartered?
Mellitus, LLC is headquartered in Boston, Massachusetts, United States.
What does Mellitus do?
Mellitus, LLC is a biotechnology company.
When was Mellitus founded?
The earliest incorporation on record for Mellitus, LLC is in 2011, according to public company registers.
Similar companies
- Elucid Bioimaging Inc.Boston, Massachusetts, United States
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.